May 27, 2026
Cardiosense Receives FDA De Novo Classification for Novel Cardiac Technology Designed to Improve Care for Patients with Heart Failure
Read More
May 21, 2026
Antag Therapeutics appoints obesity treatment pioneer Philip Just Larsen as Chief Executive Officer
Read More
May 20, 2026
HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Clinical Trial of HTX-001
Read More
May 14, 2026
Nyra Medical to Highlight First-in-Human Clinical Insights Through Three Presentations at EuroPCR
Read More
Mar 18, 2026
IsomAb appoints Dr Philip Brainin as Chief Executive Officer
Download PDF
Jan 12, 2026
Abbott and AtaCor Medical Collaborate on Advanced Extravascular ICD Technology
Read More
1234